MedTrace Logo

French Childhood Cancer Survivor Study

NCT01620372 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 18000

Last updated 2012-10-10

No results posted yet for this study

Summary

The FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years.

The study is concerned by improving knowledge about the long-term effects caused by cancer and its treatments including adverse health and social outcomes.

The main reason of the FCCSS is to estimate the risk of adverse health and social outcomes that may occur after a cancer treatment and to prevent them by providing adapted follow-up care.

The cohort will be followed for up to 20 years from 2011.

Conditions

  • Childhood Solid Tumor

Sponsors & Collaborators

  • Ligue contre le cancer, France

    collaborator OTHER

  • National Research Agency, France

    collaborator OTHER

  • Programme hospitalier de recherche clinique, France

    collaborator UNKNOWN

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Florent F. de Vathaire, Ph.D. · Institut National de la Santé Et de la Recherche Médicale, France

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Completion
2031-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01620372 on ClinicalTrials.gov